Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma. [electronic resource]
Producer: 19980701Description: 2169-80 p. digitalISSN:- 0732-183X
- Adult
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Child
- Child, Preschool
- Complement C3 -- analysis
- Complement C4 -- analysis
- Complement Hemolytic Activity Assay
- Female
- Fluorescent Antibody Technique, Indirect
- Gangliosides -- immunology
- Humans
- Infusions, Intravenous
- Male
- Mice
- Neuroblastoma -- metabolism
- Osteosarcoma -- therapy
- Pain -- chemically induced
- Recombinant Fusion Proteins -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.